NPPA Panel Rejects Intas’ Application For Exemption Of Clozapine Extended Release Capsules
New Delhi : The expert panel of National Pharmaceutical Pricing Authority (NPPA) has once again rejected the application by Intas Pharmaceuticals Ltd for exemption from the provisions of Drug Price…